Skip to main content
Top
Published in: Arthritis Research & Therapy 2/2009

01-04-2009 | Review

Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment

Authors: Maurizio Cutolo, Rainer H Straub

Published in: Arthritis Research & Therapy | Issue 2/2009

Login to get access

Abstract

The neuroendocrine immune (NEI) system is regarded as a fundamental network for the maintenance of health status (homeostasis), and it plays an important role in several systemic diseases, including autoimmune disorders. Among the major players of NEI pathways are steroid hormones of the adrenal (cortisol) and gonadal glands (sex hormones), neurohormones such as melatonin, and more recently the vitamin D endocrine system. Estrogens, melatonin and chronic stress (inducing decreased adrenal glucocorticoid release over a long time) strongly modulate the NEI system and stimulate the immune response. The vitamin D endocrine system is regarded as a potential immunosuppressive factor. Consequently, estrogens (especially in patients affected by B-cell-driven immunity) and melatonin should be avoided, and glucocorticoids (as replacement therapy) and vitamin D are allowed in the treatment of autoimmunity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cutolo M, Straub RH, Bijlsma JW: Neuroendocrine-immune interactions in synovitis. Nat Clin Pract Rheumatol. 2007, 3: 627-634.CrossRefPubMed Cutolo M, Straub RH, Bijlsma JW: Neuroendocrine-immune interactions in synovitis. Nat Clin Pract Rheumatol. 2007, 3: 627-634.CrossRefPubMed
2.
go back to reference Buttgereit F, Zhou H, Seibel MJ: Arthritis and endogenous glucocorticoids: the emerging role of the 11β-HSD enzymes. Ann Rheum Dis. 2008, 67: 1201-1203.CrossRefPubMed Buttgereit F, Zhou H, Seibel MJ: Arthritis and endogenous glucocorticoids: the emerging role of the 11β-HSD enzymes. Ann Rheum Dis. 2008, 67: 1201-1203.CrossRefPubMed
3.
go back to reference Adorini L, Penna G: Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008, 4: 404-412.CrossRefPubMed Adorini L, Penna G: Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008, 4: 404-412.CrossRefPubMed
4.
go back to reference Elenkov IJ, Chrousos GP: Stress system – organization, physiology and immunoregulation. Neuroimmunomodulation. 2006, 13: 257-267.CrossRefPubMed Elenkov IJ, Chrousos GP: Stress system – organization, physiology and immunoregulation. Neuroimmunomodulation. 2006, 13: 257-267.CrossRefPubMed
5.
go back to reference Cutolo M, Straub RH: Stress as a risk factor in the pathogenesis of rheumatoid arthritis. Neuroimmunomodulation. 2006, 13: 277-282.CrossRefPubMed Cutolo M, Straub RH: Stress as a risk factor in the pathogenesis of rheumatoid arthritis. Neuroimmunomodulation. 2006, 13: 277-282.CrossRefPubMed
6.
go back to reference Bijlsma JW, Hoes JN, Van Everdingen AA, Verstappen SM, Jacobs JW: Are glucocorticoids DMARDs?. Ann NY Acad Sci. 2006, 1069: 268-274.CrossRefPubMed Bijlsma JW, Hoes JN, Van Everdingen AA, Verstappen SM, Jacobs JW: Are glucocorticoids DMARDs?. Ann NY Acad Sci. 2006, 1069: 268-274.CrossRefPubMed
7.
go back to reference Straub RH, Pongratz G, Cutolo M, Wijbrandts CA, Baeten D, Fleck M, Atzeni F, Grunke M, Kalden JR, Schölmerich J, Lorenz HM, Tak PP, Sarzi-Puttini P: Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Rheum. 2008, 58: 976-978.CrossRefPubMed Straub RH, Pongratz G, Cutolo M, Wijbrandts CA, Baeten D, Fleck M, Atzeni F, Grunke M, Kalden JR, Schölmerich J, Lorenz HM, Tak PP, Sarzi-Puttini P: Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Rheum. 2008, 58: 976-978.CrossRefPubMed
8.
go back to reference Cutolo M, Cimmino MA, Sulli A: Polymyalgia rheumatica vs late-onset rheumatoid arthritis. Rheumatology (Oxford). 2009, 48: 93-95.CrossRef Cutolo M, Cimmino MA, Sulli A: Polymyalgia rheumatica vs late-onset rheumatoid arthritis. Rheumatology (Oxford). 2009, 48: 93-95.CrossRef
9.
go back to reference Straub RH, Cutolo M: Further evidence for insufficient hypothalamic–pituitary–glandular axes in polymyalgia rheumatica. J Rheumatol. 2006, 33: 1219-1223.PubMed Straub RH, Cutolo M: Further evidence for insufficient hypothalamic–pituitary–glandular axes in polymyalgia rheumatica. J Rheumatol. 2006, 33: 1219-1223.PubMed
10.
go back to reference Straub RH, Cutolo M: Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum. 2007, 56: 399-408.CrossRefPubMed Straub RH, Cutolo M: Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum. 2007, 56: 399-408.CrossRefPubMed
12.
go back to reference Arvidson NG, Gudbjornsson B, Elfman L, Ryden AC, Totterman TH, Hallgren R: Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis. 1994, 53: 521-524.PubMedCentralCrossRefPubMed Arvidson NG, Gudbjornsson B, Elfman L, Ryden AC, Totterman TH, Hallgren R: Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis. 1994, 53: 521-524.PubMedCentralCrossRefPubMed
13.
go back to reference Cutolo M, Straub RH, Buttgereit F: Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside. Ann Rheum Dis. 2008, 67: 905-908.CrossRefPubMed Cutolo M, Straub RH, Buttgereit F: Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside. Ann Rheum Dis. 2008, 67: 905-908.CrossRefPubMed
14.
go back to reference Bijlsma JW, Jacobs J: Innovative use of glucocorticoids in patients with rheumatoid arthritis. Lancet. 2008, 371: 183-184.CrossRefPubMed Bijlsma JW, Jacobs J: Innovative use of glucocorticoids in patients with rheumatoid arthritis. Lancet. 2008, 371: 183-184.CrossRefPubMed
15.
go back to reference Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, GromnicaIhle E, Jeka S, Krueger K, Szechinski J, Alten R: Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet. 2008, 371: 183-184.CrossRef Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, GromnicaIhle E, Jeka S, Krueger K, Szechinski J, Alten R: Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet. 2008, 371: 183-184.CrossRef
16.
go back to reference Hoes JN, Jacobs JW, Boers M, Boumpas D, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Esselens G, Guillevin L, Hafstrom I, Kirwan JR, Rovensky J, Russell A, Saag KG, Svensson B, Westhovens R, Zeidler H, Bijlsma JW: EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis. 2007, 66: 1560-1567.PubMedCentralCrossRefPubMed Hoes JN, Jacobs JW, Boers M, Boumpas D, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Esselens G, Guillevin L, Hafstrom I, Kirwan JR, Rovensky J, Russell A, Saag KG, Svensson B, Westhovens R, Zeidler H, Bijlsma JW: EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis. 2007, 66: 1560-1567.PubMedCentralCrossRefPubMed
17.
go back to reference Garcia-Maurino S, Gonzalez-Haba MG, Calvo JR, Rafii-El-Idrissi M, Sanchez-Margalet V, Goberna R, Guerrero JM: Melatonin enhances IL-2, IL-6, and IFN-γ production by human circulating CD4+ cells. J Immunol. 1997, 159: 574-581.PubMed Garcia-Maurino S, Gonzalez-Haba MG, Calvo JR, Rafii-El-Idrissi M, Sanchez-Margalet V, Goberna R, Guerrero JM: Melatonin enhances IL-2, IL-6, and IFN-γ production by human circulating CD4+ cells. J Immunol. 1997, 159: 574-581.PubMed
18.
go back to reference Cutolo M, Villaggio B, Candido F, Valenti S, Giusti M, Felli L, Sulli A, Accardo S: Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cells. Ann NY Acad Sci. 1999, 876: 246-254.CrossRefPubMed Cutolo M, Villaggio B, Candido F, Valenti S, Giusti M, Felli L, Sulli A, Accardo S: Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cells. Ann NY Acad Sci. 1999, 876: 246-254.CrossRefPubMed
19.
go back to reference Petrovsky N, McNair P, Harrison LC: Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine. 1998, 10: 307-312.CrossRefPubMed Petrovsky N, McNair P, Harrison LC: Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine. 1998, 10: 307-312.CrossRefPubMed
20.
go back to reference Forrest CM, Mackay GM, Stoy N, Stone TW, Darlington LG: Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol. 2007, 64: 517-526.PubMedCentralCrossRefPubMed Forrest CM, Mackay GM, Stoy N, Stone TW, Darlington LG: Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol. 2007, 64: 517-526.PubMedCentralCrossRefPubMed
21.
go back to reference Cutolo M, Maestroni GJ, Otsa K, Aakre O, Villaggio B, Capellino S, Montagna P, Fazzuoli L, Veldi T, Peets T, Hertens E, Sulli A: Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis. 2005, 64: 212-216.PubMedCentralCrossRefPubMed Cutolo M, Maestroni GJ, Otsa K, Aakre O, Villaggio B, Capellino S, Montagna P, Fazzuoli L, Veldi T, Peets T, Hertens E, Sulli A: Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis. 2005, 64: 212-216.PubMedCentralCrossRefPubMed
23.
24.
go back to reference Cutolo M: Sex and rheumatoid arthritis: mouse model versus human disease. Arthritis Rheum. 2007, 56: 1-3.CrossRefPubMed Cutolo M: Sex and rheumatoid arthritis: mouse model versus human disease. Arthritis Rheum. 2007, 56: 1-3.CrossRefPubMed
25.
go back to reference Cutolo M, Capellino S, Straub RH: Oestrogens in rheumatic diseases: friend or foe?. Rheumatology (Oxford). 2008, 47 (Suppl 3): iii2-iii5. Cutolo M, Capellino S, Straub RH: Oestrogens in rheumatic diseases: friend or foe?. Rheumatology (Oxford). 2008, 47 (Suppl 3): iii2-iii5.
26.
go back to reference Castagnetta LA, Carruba G, Granata OM, Stefano R, Miele M, Schmidt M, Cutolo M, Straub RH: Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol. 2003, 30: 2597-2605.PubMed Castagnetta LA, Carruba G, Granata OM, Stefano R, Miele M, Schmidt M, Cutolo M, Straub RH: Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol. 2003, 30: 2597-2605.PubMed
27.
go back to reference Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, Straub RH: Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus. 2004, 13: 635-638.CrossRefPubMed Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, Straub RH: Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus. 2004, 13: 635-638.CrossRefPubMed
28.
go back to reference Hughes GC, Clark EA: Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity. 2007, 40: 470-481.CrossRefPubMed Hughes GC, Clark EA: Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity. 2007, 40: 470-481.CrossRefPubMed
29.
go back to reference Cohen-Solal JF, Jeganathan V, Grimaldi CM, Peeva E, Diamond B: Sex hormones and SLE: influencing the fate of autoreactive B cells. Curr Top Microbiol Immunol. 2006, 305: 67-88.PubMed Cohen-Solal JF, Jeganathan V, Grimaldi CM, Peeva E, Diamond B: Sex hormones and SLE: influencing the fate of autoreactive B cells. Curr Top Microbiol Immunol. 2006, 305: 67-88.PubMed
30.
go back to reference Cutolo M, Capellino S, Sulli A, Serioli B, Secchi ME, Villaggio B, Straub RH: Estrogens and autoimmune diseases. Ann NY Acad Sci. 2006, 1089: 538-547.CrossRefPubMed Cutolo M, Capellino S, Sulli A, Serioli B, Secchi ME, Villaggio B, Straub RH: Estrogens and autoimmune diseases. Ann NY Acad Sci. 2006, 1089: 538-547.CrossRefPubMed
31.
go back to reference Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, Straub RH: Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus. 2004, 13: 635-638.CrossRefPubMed Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, Straub RH: Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus. 2004, 13: 635-638.CrossRefPubMed
32.
go back to reference Ganesan K, Selvam R, Abhirami R, Raju KV, Manohar BM, Puvanakrishnan R: Gender differences and protective effects of testosterone in collagen induced arthritis in rats. Rheumatol Int. 2008, 28: 345-353.CrossRefPubMed Ganesan K, Selvam R, Abhirami R, Raju KV, Manohar BM, Puvanakrishnan R: Gender differences and protective effects of testosterone in collagen induced arthritis in rats. Rheumatol Int. 2008, 28: 345-353.CrossRefPubMed
33.
go back to reference Adorini L: Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol. 2007, 233: 115-124.CrossRef Adorini L: Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol. 2007, 233: 115-124.CrossRef
34.
go back to reference van Etten E, Mathieu C: Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005, 97: 93-101.CrossRefPubMed van Etten E, Mathieu C: Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005, 97: 93-101.CrossRefPubMed
35.
go back to reference Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, Kilby MD, Moss PA, Chakraverty R: Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003, 170: 5382-5390.CrossRefPubMed Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, Kilby MD, Moss PA, Chakraverty R: Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003, 170: 5382-5390.CrossRefPubMed
36.
go back to reference Cadranel J, Garabedian M, Milleron B, Guillozo H, Akoun G, Hance AJ: 1,25(OH)2 D3 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J Clin Invest. 1990, 85: 1588-1593.PubMedCentralCrossRefPubMed Cadranel J, Garabedian M, Milleron B, Guillozo H, Akoun G, Hance AJ: 1,25(OH)2 D3 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J Clin Invest. 1990, 85: 1588-1593.PubMedCentralCrossRefPubMed
37.
go back to reference Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE: Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007, 179: 1634-1647.CrossRefPubMed Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE: Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007, 179: 1634-1647.CrossRefPubMed
38.
39.
go back to reference Mahon BD, Wittke A, Weaver V, Cantorna MT: The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem. 2003, 89: 922-932.CrossRefPubMed Mahon BD, Wittke A, Weaver V, Cantorna MT: The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem. 2003, 89: 922-932.CrossRefPubMed
40.
go back to reference Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A: 1α,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001, 167: 4974-4980.CrossRefPubMed Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A: 1α,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001, 167: 4974-4980.CrossRefPubMed
41.
go back to reference Cantorna MT, Mahon BD: Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004, 229: 1136-1142. Cantorna MT, Mahon BD: Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004, 229: 1136-1142.
42.
go back to reference Staeva-Vieira TP, Freedman LP: 1,25-dihydroxyvitamin D3 inhibits IFNγ and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol. 2002, 168: 1181-1189.CrossRefPubMed Staeva-Vieira TP, Freedman LP: 1,25-dihydroxyvitamin D3 inhibits IFNγ and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol. 2002, 168: 1181-1189.CrossRefPubMed
43.
go back to reference Heine G, Niesner U, Chang HD, Steinmeyer A, Zügel U, Zuberbier T, Radbruch A, Worm M: 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol. 2008, 38: 2210-2218.CrossRefPubMed Heine G, Niesner U, Chang HD, Steinmeyer A, Zügel U, Zuberbier T, Radbruch A, Worm M: 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol. 2008, 38: 2210-2218.CrossRefPubMed
44.
45.
go back to reference Linker-Israeli M, Elstner E, Klinenberg JR, Wallace DJ, Koeffler HP: Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol. 2001, 99: 82-93.CrossRefPubMed Linker-Israeli M, Elstner E, Klinenberg JR, Wallace DJ, Koeffler HP: Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol. 2001, 99: 82-93.CrossRefPubMed
46.
go back to reference Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R: Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun. 2000, 270: 701-708.CrossRefPubMed Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R: Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun. 2000, 270: 701-708.CrossRefPubMed
47.
go back to reference Helming L, Bose J, Ehrchen J, Chiebe S, Frahm T, Geffers R, Probst-Kepper M, Balling R, Lengeling A: 1α,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood. 2005, 106: 4351-4358.CrossRefPubMed Helming L, Bose J, Ehrchen J, Chiebe S, Frahm T, Geffers R, Probst-Kepper M, Balling R, Lengeling A: 1α,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood. 2005, 106: 4351-4358.CrossRefPubMed
48.
go back to reference Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A: Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004, 62: 60-65.CrossRefPubMed Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A: Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004, 62: 60-65.CrossRefPubMed
49.
go back to reference Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B: Vitamin D in rheumatoid arthritis. Autoimmun Rev. 2007, 7: 59-64.CrossRefPubMed Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B: Vitamin D in rheumatoid arthritis. Autoimmun Rev. 2007, 7: 59-64.CrossRefPubMed
50.
go back to reference Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, Sulli A, Paolino S, Seriolo B: Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol. 2006, 24: 702-704.PubMed Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, Sulli A, Paolino S, Seriolo B: Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol. 2006, 24: 702-704.PubMed
51.
go back to reference Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C: Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford). 2008, 47: 920-923.CrossRef Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C: Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford). 2008, 47: 920-923.CrossRef
52.
go back to reference Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, Zeher M, Szegedi G, Bodolay E: Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther. 2008, 10 (5): R123-PubMedCentralCrossRefPubMed Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, Zeher M, Szegedi G, Bodolay E: Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther. 2008, 10 (5): R123-PubMedCentralCrossRefPubMed
53.
go back to reference Cutolo M: Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. Arthritis Res Ther. 2008, 6: 123-CrossRef Cutolo M: Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. Arthritis Res Ther. 2008, 6: 123-CrossRef
54.
go back to reference Cutolo M, Otsa K, Paolino S, Yprus M, Veldi T, Seriolo B: Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis. 2009, 68: 446-447.CrossRefPubMed Cutolo M, Otsa K, Paolino S, Yprus M, Veldi T, Seriolo B: Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis. 2009, 68: 446-447.CrossRefPubMed
Metadata
Title
Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment
Authors
Maurizio Cutolo
Rainer H Straub
Publication date
01-04-2009
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 2/2009
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2630

Other articles of this Issue 2/2009

Arthritis Research & Therapy 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.